SCHEMBL7654586

SCHEMBL7654586

CCCCOCc1oc(-c2ccc(F)c(F)c2F)nc1C

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
VDR P11473 6/20 0.35
PPARD Q03181 9/20 0.34
FFAR1 O14842 1/20 0.34
PDE2A O00408 8/20 0.33
PPARG P37231 4/20 0.32
ESR1 P03372 3/20 0.32
THRA P10827 3/20 0.32
THRB P10828 3/20 0.32
RXRA P19793 3/20 0.32
PPARA Q07869 3/20 0.32
ESR2 Q92731 3/20 0.32
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7662468 0.82 VDR (0.41) VDRPPARDFFAR1PPARGESR1
SCHEMBL4435927 0.70 PPARD (0.44) VDRPPARDPPARGESR1THRA
SCHEMBL6075822 0.66 TRPV3 (0.32)
SCHEMBL16855833 0.59 CYP1A2 (0.44) ESR1
SCHEMBL15131365 0.59 L3MBTL1 (0.46) FFAR1ESR1THRATHRB
SCHEMBL28158410 0.59 TSHR (0.40) ESR1
SCHEMBL5716618 0.58 CTSL (0.44) ESR1ESR2
SCHEMBL6457941 0.57 CTSL (0.37)
SCHEMBL8297105 0.57 LTA4H (0.38) FFAR1
SCHEMBL16855828 0.57 CYP1A2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462068-B1 CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
US-6414009-B1 CARDIOVASCULAR DISORDERS; ANTICOAGULANTS BAYER AKTIENGESELLSCHAFT (DE) 2002-07-02 US disclosed
US-6410740-B1 CYCLIZATION OF THE CORRESPONDING AMIDE BAYER AKTIENGESELLSCHAFT (DE) 2002-06-25 US disclosed
US-6387940-B1 CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6166027-A Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases BAYER AKTIENGESELLSCHAFT (DE) 2000-12-26 US disclosed